Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
1.10
Dollar change
+0.01
Percentage change
0.92
%
Index- P/E- EPS (ttm)-1.16 Insider Own6.18% Shs Outstand11.43M Perf Week-3.08%
Market Cap0.63M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.53M Perf Month0.92%
Income-14.14M PEG- EPS next Q- Inst Own0.51% Short Float6.53% Perf Quarter-36.78%
Sales1.70M P/S0.37 EPS this Y- Inst Trans297.32% Short Ratio0.03 Perf Half Y-41.49%
Book/sh0.28 P/B3.94 EPS next Y- ROA-76.89% Short Interest0.03M Perf Year-80.45%
Cash/sh20.12 P/C0.05 EPS next 5Y- ROE-141.60% 52W Range0.94 - 9.38 Perf YTD-72.29%
Dividend Est.- P/FCF- EPS past 5Y- ROI-262.37% 52W High-88.27% Beta1.12
Dividend TTM- Quick Ratio1.40 Sales past 5Y-25.90% Gross Margin30.66% 52W Low17.02% ATR (14)0.14
Dividend Ex-Date- Current Ratio1.47 EPS Y/Y TTM95.64% Oper. Margin-810.70% RSI (14)48.07 Volatility9.88% 12.74%
Employees78 Debt/Eq0.62 Sales Y/Y TTM-38.81% Profit Margin-830.10% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q- Payout- Rel Volume0.25 Prev Close1.09
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume1.07M Price1.10
SMA20-0.20% SMA50-5.90% SMA200-45.16% Trades Volume270,641 Change0.92%
Oct-26-23 04:05PM
Oct-04-23 08:30AM
Aug-02-23 06:03AM
May-10-23 08:00AM
Mar-29-23 09:43AM
08:00AM Loading…
Nov-07-22 08:00AM
May-18-22 12:30PM
Mar-14-22 10:33PM
Jan-20-22 12:30PM
10:45AM
Jan-18-22 07:46AM
06:47AM
Jan-14-22 05:43PM
02:00PM
Dec-16-21 08:00AM
08:00AM Loading…
Oct-18-21 08:00AM
Feb-19-21 08:00AM
Nov-26-20 08:16PM
Sep-09-20 09:00AM
May-29-20 03:08PM
Mar-16-20 09:00AM
Jan-28-20 09:35AM
Jan-24-20 02:23PM
Jan-16-20 08:00AM
Jan-03-20 10:30AM
Dec-04-19 07:10AM
Nov-14-19 11:30AM
Sep-11-19 07:00AM
Aug-19-19 08:00AM
Aug-12-19 08:00AM
08:00AM Loading…
Jul-03-19 08:00AM
May-22-19 11:20AM
Apr-17-19 09:00AM
Apr-02-19 06:30AM
Mar-28-19 06:30AM
Jan-30-19 02:25PM
Jan-04-19 07:30AM
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.